🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
There is an increasing interest in the use of metformin in CV diseases and ...
Status
Completed
Location
Agouza Hospital
Start Date
2021-07-21
Trial ID
NCT05177588
Treatments Being Tested
This study will assess the safety, tolerability and glucose-lowering effica...
Status
Completed
Location
Multiple Locations
Start Date
2006-08-11
Trial ID
NCT02004886
The purpose of this study is to determine the effects of LX4211 and metform...
Status
Completed
Location
Lexicon Investigational Site
Start Date
2011-02
Trial ID
NCT01292993
Treatments Being Tested
This research will help us to learn if the medicine called metformin reduce...
Status
Recruiting
Location
Phoenix VA Health Care System, Phoenix, AZ
Start Date
2023-04-03
Trial ID
NCT02915198
Treatments Being Tested
Epidemiologic, social and economic burdens of type 2 diabetes mellitus (T2D...
Status
Completed
Location
Azienda Ospedaliero Universitaria di Parma
Start Date
2020-09-01
Trial ID
NCT04271189
Treatments Being Tested
Prediabetes is associated to an increased risk of cardiovascular disease an...
Status
Unknown
Location
Medicinkliniken, Ljungby Hospital
Start Date
2021-12-02
Trial ID
NCT05182970
Treatments Being Tested
Primary objective: To compare long-term glycemic control and preservation ...
Status
Completed
Location
Sanofi-aventis
Start Date
2007-09
Trial ID
NCT00562172
Treatments Being Tested
Bioequivalence study for the fixed-dose combination of Gemigliptin/Dapaglif...
Status
Completed
Location
Jeonbuk National University Hospital
Start Date
2026-01-09
Trial ID
NCT07399470
The purpose of this study is to evaluate the bioequivalence of a fixed dose...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01463228
This was a four month dose ranging study followed by a 24 to 48 month exten...
Status
Terminated
Location
Anasazi Internal Medicine
Start Date
2009-04
Trial ID
NCT00900146
Treatments Being Tested